Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
(NASDAQ: ANIX) Delayed: 2.70 -0.07 (2.53%)
Previous Close $2.77    52 Week High $ 
Open $2.82    52 Week Low $ 
Day High $2.82    P/E N/A 
Day Low $2.66    EPS $ 
Volume 476,318